Jasper Ridge Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Jasper Ridge Partners’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-61,642	Closed	-$1.44M	–	134
2021 Q1	$1.44M	Hold	61,642	–	–	0.07%	78
2020 Q4	$1.77M	Hold	61,642	–	–	0.08%	66
2020 Q3	$1.25M	Hold	61,642	–	–	0.07%	70
2020 Q2	$1.85M	Hold	61,642	–	–	0.13%	56
2020 Q1	$1.94M	Hold	61,642	–	–	0.15%	43
2019 Q4	$2.9M	Hold	61,642	–	–	0.19%	39
2019 Q3	$398K	Hold	61,642	–	–	0.02%	72
2019 Q2	$757K	Hold	61,642	–	–	0.03%	62
2019 Q1	$835K	Sell	61,642 -1	-0%	-$9	0.04%	54
2018 Q4	$247K	Buy	+61,643	New	+$372K	0.02%	68

Other funds holding CNST

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jasper Ridge Partners's CNST Position: Q2 2021 in Review

Jasper Ridge Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 61,642 shares — an estimated $1.44M sold.

Jasper Ridge Partners first reported a position in CNST in Q4 2018 and held it in 10 quarters. The position peaked at $2.9M in Q4 2019. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Jasper Ridge Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Jasper Ridge Partners sold 61,642 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1.44M.
Jasper Ridge Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and held it in 10 quarters.
Jasper Ridge Partners's Constellation Pharmaceuticals, Inc. position peaked at $2.9M in Q4 2019.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Jasper Ridge Partners's 13F filing for Q2 2021, filed 12 Aug 2021.